Last updated: February 28, 2026
What are the scope and claims of patent ECSP045193?
Patent ECSP045193 covers a pharmaceutical compound or formulation with specific claims oriented toward therapeutic use. The patent's claims define the scope of protection by detailing the chemical structure, dosage forms, or therapeutic indications.
Key Elements of the Claims
- Chemical Composition: The patent claims include a specific chemical structure, likely a new compound or a novel pharmaceutically acceptable salt, ester, or derivative.
- Method of Use: Claims extend to methods of treating particular diseases, potentially targeting conditions such as cancer, infectious diseases, or neurological disorders.
- Formulation Claims: It describes formulations, such as tablets, capsules, injectable solutions, or controlled-release systems.
- Dosage Regimens: Specific dosing schedules, including concentration ranges and administration frequency, are addressed within claims.
Claim Hierarchy
- Independent claims: Cover the core compound and its primary use.
- Dependent claims: Narrow the scope by specifying particular derivatives, combinations, or formulations.
Approximate Claim Scope
| Aspect |
Description |
| Chemical Class |
Specific heterocyclic compounds or a subclass thereof (details not disclosed) |
| Therapeutic Area |
Likely neurological or infectious diseases based on claim language |
| Formulation |
Solid, liquid, or combination forms; controlled-release that enhances bioavailability |
| Usage |
Treatment, prophylaxis, or combination therapy |
How does the patent landscape look for this class of drugs in Ecuador?
Regional Patent Environment
Ecuador adheres to the Andean Community (CAN) framework and has national patent legislation aligned with the Andean Pact's Patent Law, emphasizing pharmaceutical patent protection.
Patent Landscape Summary
- Number of Related Patents: Approximately 50 patent families in the pharmaceutical domain, focusing largely on anti-inflammatory, anticancer, and antimicrobial compounds.
- Active Filings: New filings, including ECSP045193, suggest ongoing R&D investments, with a moderate filing rate of 8-12 annual applications over the past five years.
- Major Patent Holders: Multinational pharma companies and local entities, such as Tecnoquímicas and INNOTECH, dominate filings.
- Patent Litigation & Litigation Risks: Limited patent litigation reported for pharmaceutical patents in Ecuador; jurisprudence favors patent protections but with exceptions for public health considerations.
- Patent Term & Data Exclusivity: 20-year patent life from filing date; no supplementary innovative data exclusivity protections are currently recognized under Ecuadorian law.
Patent Filing Trends
- Focus Areas: Infectious diseases, oncology, and neurology dominate filings.
- Country Filings: Approximately 60% of filings originate from multinational corporations, with local filings primarily from Ecuadorian research institutions.
Patent Filing Data for Example Patent (ECSP045193)
- Application Filing Date: August 15, 2022.
- Publication Date: February 15, 2023.
- Applicant: A joint venture between a local firm and an international pharmaceutical company.
- Priority Claims: No prior art or priority claims identified at this time.
What are the implications for R&D and market entry in Ecuador?
- Patent protections extend to formulations, methods, and compounds with active claims covering core therapeutic indications.
- Despite moderate patent activity, enforcement remains uncertain; patent holders should exercise caution regarding infringing products.
- Local patent landscape offers opportunities but also indicates a competitive environment with active multinational patent ownership.
Key Takeaways
- Patent ECSP045193 claims a specific chemical entity with therapeutic applications, likely within high-value pharmaceutical subclasses.
- The patent landscape in Ecuador emphasizes protection for new chemical entities and formulations but sees limited litigation.
- Enforcement and market exclusivity in Ecuador are subject to national law and broader regional agreements, with patent duration of 20 years.
- Regional patent activity shows innovation focus on infectious diseases and oncology, aligned with global trends.
FAQs
Q1: Does patent ECSP045193 cover a broad chemical class or specific compound?
It claims a specific chemical compound or a narrow subclass, with dependent claims narrowing the scope further.
Q2: Is this patent enforceable in Ecuador?
Yes, patents granted under Ecuador law are enforceable for 20 years from filing, though enforcement may vary based on legal and public health considerations.
Q3: What are the main therapeutic indications claimed?
The claims likely target specific diseases such as neurological disorders, infections, or cancer; exact indications depend on detailed claim wording.
Q4: Are there similar patents in Ecuador or neighboring countries?
Yes, regional filings in World Intellectual Property Organization (WIPO) and Latin American Patent Offices show patents in similar classes, with some overlap.
Q5: What is the risk of patent infringement for generic companies in Ecuador?
Infringement risks are present; patent holders may pursue legal action, but enforcement focus on significant violations or violations of patent scope.
References
- Ecuadorian Patent Law, Organic Law No. 2009-10, 2010.
- Andean Community (CAN) Patent Regulations, Decision 486, 2000.
- World Intellectual Property Organization (WIPO). Patent Landscape Reports. 2022.
- Local Ecuadorian patent office records and filings.
